Vision RT and Varian commit to long-term interoperability agreement
24 October 2019. Vision RT is delighted to announce they have entered into a long-term cooperation with Varian Medical Systems, to ensure interoperability between Vision RT’s products and Varian’s TrueBeam and C-Series treatment delivery systems over the next decade and beyond.
Varian’s support of an open ecosystem enables different vendors to interface with their products. Through the VIP (Varian Interoperability Program), Vision RT’s new product releases are validated with Varian’s treatment delivery systems for supported product combinations.
About Vision RT
Vision RT defines the standard of care in Surface Guided Radiation Therapy. We provide superior solutions for the radiotherapy market, with products installed in many of the leading treatment centers in the world, including around 70% of the 50 US News “Best Hospitals for Cancer”. With approximately 70 granted patents plus more than 50 pending, we continue to innovate in the radiation oncology space and are committed to making SGRT the standard of care for all patients, worldwide.
Vision RT is part of the William Demant Invest (WDI) family, a leading Danish Medtech investor with a long-term investment perspective. The companies in WDI employ more than 18,000 people, with a total annual revenue of more than $3 billion.